Magnetic resonance study for GABA content in the brain of migraine patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025868

Enrollment

Unknown

Registered

2019-09-12

Start date

2019-09-20

Completion date

Unknown

Last updated

2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

migraine patients group and healthy people group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Comply with the diagnostic criteria for migraine in the 2013 International Headache Classification, 3rd Edition (ICHD-3ß version);

Exclusion criteria

Exclusion criteria: 1. There are other history of acute and chronic pain; 2. A recent history of medication (within January); 3. History of previous pacemakers, prosthetic heart valves, coronary stents, steel nail plates, and birth control rings. 4. There are other organic diseases or cerebrovascular diseases in the skull; 5. There is neurological disease and mental illness, or there is history of medication for psychotropic drugs.

Design outcomes

Primary

Measure	Time frame
GABA+/Glx;	—

Countries

China

Contacts

Public ContactYonggang Li

The First Affiliated Hospital of Soochow University

liyonggang224@163.com+86 17315586850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026